Apr 2, 2020 | Krka - Workforce | Chart | Slovenia | Pharmaceutical | Krka | 125% |
Apr 2, 2020 | Krka - from EBITDA to Net Profit | Chart | Slovenia | Pharmaceutical | Krka | 75% |
Apr 2, 2020 | Krka - Profits & Sales | Chart | Slovenia | Pharmaceutical | Krka | 75% |
Apr 2, 2020 | Krka - Free Cash Generation | Chart | Slovenia | Pharmaceutical | Krka | 75% |
Apr 2, 2020 | Krka - Price to Earnings & EV/EBITDA | Chart | Slovenia | Pharmaceutical | Krka | 63% |
Apr 2, 2020 | Krka - Indebtedness | Chart | Slovenia | Pharmaceutical | Krka | 25% |
Apr 2, 2020 | Krka's Cash & Cash Equivalents rose 51.9% yoy to EUR 35.8 mil in 2015 | News | Slovenia | Pharmaceutical | Krka | 25% |
Apr 2, 2020 | Krka - Cash Flow | Chart | Slovenia | Pharmaceutical | Krka | 25% |
Apr 2, 2020 | Krka - Profitability | Chart | Slovenia | Pharmaceutical | Krka | 25% |
Apr 3, 2020 | Krka - Profit Margins | Chart | Slovenia | Pharmaceutical | Krka | 13% |
Apr 2, 2020 | How Much Does Krka Invests? | Chart | Slovenia | Pharmaceutical | Krka | 13% |
Apr 2, 2020 | Krka - Stock Price & Market Capitalization | Chart | Slovenia | Pharmaceutical | Krka | 13% |